Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4863392 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL4865770 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL1334347 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL828966 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL1335248 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL4868376 | 1.00 | LIPG (0.43) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL677099 | 0.98 | LIPG (0.40) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL8038723 | 0.92 | LIPG (0.41) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL3001599 | 0.92 | LIPG (0.41) | LIPGTYRTP53CYP3A4MEN1 | |
| SCHEMBL677260 | 0.92 | TYR (0.38) | LIPGTYRTP53CYP3A4MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7429548-B2 | Soluble late transition metal catalysts for olefin oligomerizations III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-09-30 | — | — | US | claimed |
| EP-1620447-B1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | EXXONMOBIL CHEM PATENTS INC (US) | 2007-08-08 | — | — | EP | claimed |
| US-7161018-B2 | Soluble late transition metal catalysts for olefin oligomerizations II | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-01-09 | — | — | US | claimed |
| EP-1513854-B1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2006-11-29 | — | — | EP | claimed |
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | claimed |
| EP-1569751-B1 | METHODS FOR PREPARING CATALYSTS | EXXONMOBIL RES & ENG CO (US) | 2015-10-07 | — | — | EP | disclosed |
| EP-1718596-B1 | CATALYTIC PREPARATION OF SEVERELY STERICALLY HINDERED AMINO-ETHER ALCOHOLS USING A METAL LOADED CATALYST | EXXONMOBIL RES & ENG CO (US) | 2014-08-27 | — | — | EP | disclosed |
| US-8288025-B2 | High performance polymeric blend membrane materials based on N-heterocycles and acid-base interactions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-10-16 | — | — | US | disclosed |
| US-8143438-B2 | Hydrogenation processes | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2012-03-27 | — | — | US | disclosed |
| CN-1717278-B | Process for preparing catalyst | EXXONMOBIL RES & ENG CO | 2011-07-13 | — | — | CN | disclosed |
| US-20110082311-A1 | Hydrogenation Processes | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2011-04-07 | — | — | US | disclosed |
| US-7875742-B2 | hydrogenating organic compounds by contacting with hydrogen-containing gas in presence of catalyst which comprises catalytically active metals applied to porous catalyst support; catalytically active metals having been derived via decomposed amine complex of metal on support | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-01-25 | — | — | US | disclosed |
| US-6916965-B2 | Treatment of acid catalysts | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2005-07-12 | — | — | US | disclosed |
| EP-1490172-A1 | TREATMENT OF ACID CATALYSTS WITH NITROGEN COMPOUNDS | ExxonMobil Chemical Patents Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040157732-A1 | Treating an activated metalloaluminophosphate molecular sieve with one or more nitrogen containing compounds (aliphatic, aromatic, hetetrocycic or organonitrile compounds) to chemisorb and/or physisorb nitrogen-compound | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-08-12 | — | — | US | disclosed |
| US-6756516-B2 | Treatment of acid catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-06-29 | — | — | US | disclosed |
| WO-2004046076-A2 | HYDROGENATION CATALYST, PREPARATION THEREOF AND HYDROGENATION PROCESSES USING THIS CATALYST | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2004045767-A2 | METHODS FOR PREPARING CATALYSTS | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2004-06-03 | — | — | WO | disclosed |
| WO-2003084661-A1 | TREATMENT OF ACID CATALYSTS WITH NITROGEN COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-10-16 | — | — | WO | disclosed |
| US-20030004056-A1 | Treatment of acid catalysts | EXXONMOBIL CHEMICAL PATENTS INC. | 2003-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110082311-A1 | Hydrogenation Processes | HAO2, HVCN1, AOC3 | LIPG 1637/4885TYR 468/4885TP53 4757/4885 |
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | LIPG 3770/4885TYR 275/4885TP53 1482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.